301 related articles for article (PubMed ID: 26243374)
1. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
Masdrakis VG; Markianos M; Oulis P
Psychiatry Res; 2015 Sep; 229(1-2):75-81. PubMed ID: 26243374
[TBL] [Abstract][Full Text] [Related]
2. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
Abelson JL; Khan S; Liberzon I; Young EA
Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
[TBL] [Abstract][Full Text] [Related]
3. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
Abelson JL; Liberzon I; Young EA; Khan S
Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
[TBL] [Abstract][Full Text] [Related]
4. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
van Duinen MA; Schruers KR; Maes M; Griez EJ
J Psychopharmacol; 2005 May; 19(3):243-7. PubMed ID: 15888509
[TBL] [Abstract][Full Text] [Related]
5. Does the panic attack activate the hypothalamic-pituitary-adrenal axis?
Graeff FG; Garcia-Leal C; Del-Ben CM; Guimarães FS
An Acad Bras Cienc; 2005 Sep; 77(3):477-91. PubMed ID: 16127553
[TBL] [Abstract][Full Text] [Related]
6. Prolactin but not ACTH increases during sodium lactate-induced panic attacks.
Otte C; Kellner M; Arlt J; Jahn H; Holsboer F; Wiedemann K
Psychiatry Res; 2002 Mar; 109(2):201-5. PubMed ID: 11927145
[TBL] [Abstract][Full Text] [Related]
7. CO2 challenge induced HPA axis activation in panic.
van Duinen MA; Schruers KR; Maes M; Griez EJ
Int J Neuropsychopharmacol; 2007 Dec; 10(6):797-804. PubMed ID: 17076937
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.
Abelson JL; Curtis GC; Cameron OG
J Psychiatr Res; 1996; 30(2):79-93. PubMed ID: 8816303
[TBL] [Abstract][Full Text] [Related]
9. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
[TBL] [Abstract][Full Text] [Related]
10. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
Jakuszkowiak-Wojten K; Landowski J; Wiglusz MS; Cubała WJ
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.
Abelson JL; Curtis GC
Arch Gen Psychiatry; 1996 Apr; 53(4):323-31. PubMed ID: 8634010
[TBL] [Abstract][Full Text] [Related]
12. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
Zwanzger P; Eser D; Aicher S; Schüle C; Baghai TC; Padberg F; Ella R; Möller HJ; Rupprecht R
Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
[TBL] [Abstract][Full Text] [Related]
13. Effects of intravenous caffeine administered to healthy males during sleep.
Lin AS; Uhde TW; Slate SO; McCann UD
Depress Anxiety; 1997; 5(1):21-8. PubMed ID: 9250437
[TBL] [Abstract][Full Text] [Related]
14. [Anxiety, panic and the hypothalamic-pituitary-adrenal axis].
Graeff FG
Braz J Psychiatry; 2007 May; 29 Suppl 1():S3-6. PubMed ID: 17546345
[TBL] [Abstract][Full Text] [Related]
15. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820
[TBL] [Abstract][Full Text] [Related]
16. Comparison of methods for evaluation of the suppressive effects of prednisolone on the HPA axis and bone turnover: changes in s-DHEAS are as sensitive as the ACTH test.
Gruvstad E; Hedner LP; Höglund P; Luts A; Norjavaara E
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):15-26. PubMed ID: 24120714
[TBL] [Abstract][Full Text] [Related]
17. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
Belgorodsky A; Knyazhansky L; Loewenthal U; Arbelle J; Cohen H; Benjamin J
Depress Anxiety; 2005; 21(3):143-8. PubMed ID: 16001448
[TBL] [Abstract][Full Text] [Related]
18. Salivary cortisol in panic: are males more vulnerable?
van Duinen MA; Schruers KR; Jaegers E; Maes M; Griez EJ
Neuro Endocrinol Lett; 2004 Oct; 25(5):386-90. PubMed ID: 15580175
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary-adrenal axis activity in panic disorder: prediction of long-term outcome by pretreatment cortisol levels.
Abelson JL; Curtis GC
Am J Psychiatry; 1996 Jan; 153(1):69-73. PubMed ID: 8540595
[TBL] [Abstract][Full Text] [Related]
20. Caffeine challenge and breath-holding duration in patients with panic disorder.
Masdrakis VG; Markianos M; Vaidakis N; Papakostas YG; Oulis P
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):41-4. PubMed ID: 18930777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
